UPDATED Jul 25, 2024
Discover small cap Norwegian Pharmaceuticals & Biotech companies that are on the OSEAX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SOFTX | NOK 0.067 | -17.3% | -99.2% | NOK 34.5m | n/a | PE-0.6x | n/a | n/a | ||
CRNA | NOK 2.16 | -6.1% | -87.4% | NOK 40.0m | NOK 3.00 | PS325.2x | E97.8% | n/a | ||
PCIB | NOK 1.85 | 3.9% | -3.8% | NOK 69.0m | n/a | PS23.1x | n/a | n/a | ||
NORD | NOK 41.00 | 0% | n/a | NOK 203.8m | n/a | n/a | n/a | 0% | ||
EXTX | NOK 7.15 | -10.1% | -37.8% | NOK 229.4m | n/a | PS51452.7x | n/a | n/a | ||
NANOV | NOK 2.00 | -18.3% | -22.2% | NOK 231.8m | n/a | PB3.6x | n/a | n/a | ||
TRMED | NOK 1.04 | -1.9% | -39.9% | NOK 243.3m | n/a | PB0.9x | n/a | n/a | ||
ABS | NOK 10.50 | 0% | -2.3% | NOK 266.4m | NOK 10.00 | PS7.9x | E-6.0% | n/a | ||
ULTI | NOK 7.93 | 7.2% | -89.8% | NOK 272.8m | NOK 6.50 | PB1.1x | E28.5% | n/a | ||
LYTIX | NOK 8.90 | 4.7% | 34.8% | NOK 441.5m | NOK 13.00 | PS30.4x | S110.7% | n/a | ||
BGBIO | NOK 12.85 | 2.0% | 20.4% | NOK 502.4m | NOK 30.67 | PS964.3x | E-24.9% | n/a | ||
NAVA | NOK 32.80 | -0.3% | -10.4% | NOK 571.8m | NOK 46.50 | PS1.1x | E38.9% | n/a | ||
HBC | NOK 2.03 | -4.2% | -31.2% | NOK 802.0m | n/a | PS3.5x | n/a | n/a | ||
VISTN | NOK 21.10 | -2.3% | -11.7% | NOK 935.7m | n/a | PE16.6x | n/a | 4.7% | ||
AZT | NOK 23.90 | -1.2% | -37.5% | NOK 1.2b | NOK 27.50 | PE69.5x | E48.1% | n/a | ||
PHO | NOK 54.50 | -1.1% | 18.3% | NOK 1.5b | NOK 86.00 | PE306.4x | E92.4% | 0% | ||
NYKD | NOK 14.00 | 0.7% | -51.3% | NOK 4.6b | NOK 36.63 | PS37.7x | E-17.8% | n/a |